REFERENCES
- Freeman C R, Taylor R E, Kortmann R-D, Carrie C. Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts. Med Pediatr Oncol.. 2002; 39: 99–108. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Packer R J, Cogen P, Vezina G, Rorke L B. Medulloblastoma: clinical and biologic aspects. Neuro-Oncology. 1999; 1: 232–250. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ris M D, Packer R, Goldwein J, Jones-Wallace D, Boyett J M. Intelectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol.. 2001; 19: 3470–3476. [PUBMED], [INFOTRIEVE]
- Hayani A, Mahoney D H, Jr, Taylor L D. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. J Neurooncol.. 1992; 14: 57–62. [PUBMED], [INFOTRIEVE]
- Hartmann O, Valteau-Couanet D, Dupuis S, et al, High-dose chemotherapy followed by autologous bone marrow transplantation in place of craniospinal irradiation in young children treated for medulloblastoma?. Med Pediatr Oncol.. 1995; 25: 251
- Kuhl J, Bode U, Deinlein H, et al, Cure of infants with medulloblastoma (M0/M1-stage) by postoperative chemotherapy only. Med Pediatr Oncol.. 1999; 33: 169
- Pence D M, Tae H K, Seymour H, L. Aneurysm, arachnoiditis and intrathecal Au (gold). Int J Radiat Oncol Biol Phys.. 1990; 18: 1001–1004. [PUBMED], [INFOTRIEVE]
- Döge H, Hliscs R. Intrathecal therapy with 198Au-colloid for meningosis prophylaxis. Eur J Nucl Med.. 1984; 9: 125–128
- Kramer K, Cheung N-KV, Humm J L, et al, Targeted radioimmunotherapy for leptomeningeal cancer using 131I-3F8. Med Pediatr Oncol.. 2000; 35: 716–718. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kemshead J T, Hopkins K, Pizer B, et al, Dose escalation with repeated intrathecal injections of 131I-labelled Mabs for the treatment of central nervous system malignancies. Br J Cancer. 1998; 77: 2324–2330. [PUBMED], [INFOTRIEVE]
- Kellie S J, Wong C K, Pozza L D, et al, Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children. Med Pediatr Oncol.. 2002; 39: 168–174. [CROSSREF], [PUBMED], [INFOTRIEVE]